A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, May 18, 2020.
Brian Snyder | Reuters
Moderna reported Wednesday a fivefold increase in second-quarter revenue related to its work on a potential coronavirus vaccine.
This is a developing story. Please check back for updates.
This article was originally published by Cnbc.com. Read the original article here.